Tag ccnd1 [23 articles] Export Sort

Recent papers classified by the tag ccnd1.

Hide details

	Systematic validation of predicted microRNAs for cyclin D1. [My Copy] BMC cancer, Vol. 9, No. 1. (18 June 2009), 194. by Qiong Jiang, Ming-Guang G. Feng, Yin-Yuan Y. Mo posted to mirna ccnd1 by jfr to the group microRNA on 2009-11-27 11:41:32 as along with 1 person guhjy
	CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome. [My Copy] Breast cancer research and treatment, Vol. 109, No. 2. (May 2008), pp. 325-335. by Somaia Elsheikh, Andrew R. Green, Mohammed A. Aleskandarany, et al.Matthew Grainge, Claire E. Paish, Maryou B. Lambros, Jorge S. Reis-Filho, Ian O. Ellis posted to cancer ccnd1 cyclind1 prognosis breast thelist by Zephyrus on 2009-04-27 13:44:08 as
	Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. [My Copy] FEBS letters, Vol. 582, No. 10. (30 April 2008), pp. 1564-1568. by Fang Sun, Hanjiang Fu, Qin Liu, et al.Yi Tie, Jie Zhu, Ruiyun Xing, Zhixian Sun, Xiaofei Zheng posted to ccnd1 cdk6 cell cycle microrna mir-34a by maralena on 2008-05-06 15:28:25 as along with 1 person valeriehilgers
	Identification of a naturally processed cyclin D1 T-helper epitope by a novel combination of HLA class II targeting and differential mass spectrometry. [My Copy] Eur J Immunol, Vol. 34, No. 12. (December 2004), pp. 3644-3651. by J. Dengjel, P. Decker, O. Schoor, et al.F. Altenberend, T. Weinschenk, H. G. Rammensee, S. Stevanovic posted to ccnd1 cd4 by eisei on 2008-03-18 08:14:33 as
	Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC). [My Copy] Oral Oncol, Vol. 43, No. 1. (January 2007), pp. 60-66. by K. Freier, C. Schwaenen, C. Sticht, et al.C. Flechtenmacher, J. Mühling, C. Hofele, B. Radlwimmer, P. Lichter, S. Joos posted to amplification ccnd1 cgh egfr expression fgfr oral protein scc by abhattac on 2007-12-06 20:03:08 as
	Allo-major histocompatibility complex-restricted cytotoxic T lymphocytes engraft in bone marrow transplant recipients without causing graft-versus-host disease. [My Copy] Blood, Vol. 94, No. 9. (1 November 1999), pp. 2999-3006. by L. Gao, T. H. Yang, S. Tourdot, E. Sadovnikova, R. Hasserjian, H. J. Stauss posted to ccnd1 by eisei on 2007-04-20 10:13:23 as
	Antisense to cyclin D1 inhibits VEGF-stimulated growth of vascular endothelial cells: implication of tumor vascularization. [My Copy] Clin Cancer Res, Vol. 12, No. 15. (1 August 2006), pp. 4459-4462. by R. G. Pestell, Z. Li posted to antiogenesis ccnd1 vegf by eisei on 2007-04-15 23:25:09 as
	Cyclin D1 degradation enhances endothelial cell survival upon oxidative stress. [My Copy] FASEB J, Vol. 20, No. 8. (June 2006), pp. 1242-1244. by P. Fasanaro, A. Magenta, G. Zaccagnini, et al.L. Cicchillitti, S. Fucile, F. Eusebi, P. Biglioli, M. C. Capogrossi, F. Martelli posted to ccnd1 endothelial h2o2 by eisei on 2007-04-15 23:21:42 as
	A synthetic peptide derived from the tumor-associated protein mdm2 can stimulate autoreactive, high avidity cytotoxic T lymphocytes that recognize naturally processed protein. [My Copy] J Immunol, Vol. 157, No. 1. (1 July 1996), pp. 239-246. by A. M. Dahl, P. C. Beverley, H. J. Stauss posted to ccnd1 mice by eisei on 2007-04-12 12:17:05 as
	The molecular classification of multiple myeloma. [My Copy] Blood, Vol. 108, No. 6. (15 September 2006), pp. 2020-2028. by F. Zhan, Y. Huang, S. Colla, et al.J. P. Stewart, I. Hanamura, S. Gupta, J. Epstein, S. Yaccoby, J. Sawyer, B. Burington, E. Anaissie, K. Hollmig, M. Pineda-Roman, G. Tricot, F. van Rhee, R. Walker, M. Zangari, J. Crowley, B. Barlogie, J. D. Shaughnessy posted to ccnd1 myeloma by eisei on 2007-04-03 19:12:17 as
	Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. [My Copy] Blood, Vol. 106, No. 1. (1 July 2005), pp. 296-303. by P. L. Bergsagel, W. M. Kuehl, F. Zhan, J. Sawyer, B. Barlogie, J. Shaughnessy posted to ccnd1 myeloma by eisei on 2007-04-03 19:10:55 as
	Generation of human tumor-reactive cytotoxic T cells against peptides presented by non-self HLA class I molecules. [My Copy] Eur J Immunol, Vol. 28, No. 1. (January 1998), pp. 193-200. by E. Sadovnikova, L. A. Jopling, K. S. Soo, H. J. Stauss posted to ccnd1 ctl by eisei on 2007-03-23 11:36:01 as
	Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells. [My Copy] Mol Cancer, Vol. 5 (2006) by J. P. Alao, A. V. Stavropoulou, E. W. Lam, R. C. Coombes, D. M. Vigushin posted to ccnd1 hdac by eisei on 2007-03-23 11:22:52 as
	Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling. [My Copy] Cancer Res, Vol. 67, No. 2. (15 January 2007), pp. 609-615. by L. J. Donato, J. H. Suh, N. Noy posted to ccnd1 ra by eisei on 2007-03-23 11:13:01 as
	Integrated functional genomics approach for the design of patient-individual antitumor vaccines. [My Copy] Cancer Res, Vol. 62, No. 20. (15 October 2002), pp. 5818-5827. by T. Weinschenk, C. Gouttefangeas, M. Schirle, et al.F. Obermayr, S. Walter, O. Schoor, R. Kurek, W. Loeser, K. H. Bichler, D. Wernet, S. Stevanović, H. G. Rammensee posted to ccnd1 cyclin-d1 mass-spectrometry by eisei on 2007-01-19 15:24:08 as
	Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy. [My Copy] Cancer Immunol Immunother, Vol. 54, No. 9. (September 2005), pp. 826-836. by T. Krüger, O. Schoor, C. Lemmel, et al.B. Kraemer, C. Reichle, J. Dengjel, T. Weinschenk, M. Müller, J. Hennenlotter, A. Stenzl, H. G. Rammensee, S. Stevanović posted to mass-spectrometry immunotherapy hla ccnd1 by eisei on 2007-01-19 15:19:32 as
	Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers. [My Copy] Mol Pathol, Vol. 54, No. 4. (August 2001), pp. 259-263. by S. A. Vaziri, R. R. Tubbs, G. Darlington, G. Casey posted to brca1 ccnd1 by eisei on 2007-01-03 10:54:02 as
	BRCA2 Mutation-associated Breast Cancers Exhibit a Distinguishing Phenotype Based on Morphology and Molecular Profiles From Tissue Microarrays. [My Copy] Am J Surg Pathol, Vol. 31, No. 1. (January 2007), pp. 121-128. by Anita L. Bane, Jeanne C. Beck, Ira Bleiweiss, et al.Saundra S. Buys, Edison Catalano, Mary B. Daly, Graham Giles, Andy K. Godwin, Hanina Hibshoosh, John L. Hopper, Esther M. John, Lester Layfield, Teri Longacre, Alexander Miron, Rubie Senie, Melissa C. Southey, Dee W. West, Alice S. Whittemore, Hong Wu, Irene L. Andrulis, Frances P. Oʼmalley, posted to brca2 breast ccnd1 by eisei on 2007-01-03 10:47:57 as along with 1 person jfr
	Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. [My Copy] J Biol Chem, Vol. 278, No. 32. (8 August 2003), pp. 30339-30347. by D. A. Solomon, Y. Wang, S. R. Fox, et al.T. C. Lambeck, S. Giesting, Z. Lan, A. M. Senderowicz, C. J. Conti, E. S. Knudsen posted to ccnd1 by eisei on 2006-10-05 15:17:11 as
	A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. [My Copy] Cell, Vol. 114, No. 3. (8 August 2003), pp. 323-334. by Justin Lamb, Sridhar Ramaswamy, Heide L. Ford, et al.Bernardo Contreras, Robert V. Martinez, Frances S. Kittrell, Cynthia A. Zahnow, Nick Patterson, Todd R. Golub, Mark E. Ewen posted to ccnd1 by eisei on 2006-10-05 13:49:24 as along with 1 person frohike
	PRAD1 gene over-expression in mantle-cell lymphoma but not in other low-grade B-cell lymphomas, including extranodal lymphoma. [My Copy] Br J Haematol, Vol. 86, No. 4. (April 1994), pp. 786-791. by K. Oka, T. Ohno, K. Kita, et al.M. Yamaguchi, N. Takakura, K. Nishii, H. Miwa, S. Shirakawa posted to ccnd1 by eisei on 2006-08-02 17:07:24 as
	Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer. [My Copy] Cancer Res, Vol. 66, No. 1. (1 January 2006), pp. 6-9. by A. M. Egloff, L. A. Vella, O. J. Finn posted to ccnd1 cyclin-b1 by eisei on 2006-08-02 14:35:11 as
	D cyclins in CD5+ B-cell lymphoproliferative disorders: cyclin D1 and cyclin D2 identify diagnostic groups and cyclin D1 correlates with ZAP-70 expression in chronic lymphocytic leukemia. [My Copy] Am J Clin Pathol, Vol. 125, No. 2. (February 2006), pp. 241-250. by H. J. Meyerson, G. MacLennan, W. Husel, et al.A. Cocco, W. Tse, H. M. Lazarus, D. Kaplan posted to ccnd1 by eisei on 2006-08-02 12:26:19 as

Note: You may cite this page as: http://www.citeulike.org/tag/ccnd1

Sort by:
Order:	Default Ascending Descending
Empty fields:	Default First Last

breast	2
cdk6	2
cell	2
cycle	2
mass-spectrometry	2
microrna	2
mir-34a	2
mirna	2
myeloma	2
amplification	1
antiogenesis	1
brca1	1
brca2	1
cancer	1
cd4	1
cgh	1
ctl	1
cyclin-b1	1
cyclin-d1	1
cyclind1	1
egfr	1
endothelial	1
expression	1
fgfr	1
h2o2	1
hdac	1
hla	1
immunotherapy	1
mice	1
oral	1
prognosis	1
protein	1
ra	1
scc	1
thelist	1
vegf	1

Tag ccnd1 [23 articles] Export Sort

Related Tags